hyperkalaemia Archives -

NICE has recommended extending funding via the NHS for AstraZeneca’s elevated potassium therapy Lokelma in new guidance, making

NICE expands cover for AZ’s high potassium drug Lokelma

https://pharmaphorum.com/news/nice-expands-cover-for-azs-high-potassium-drug-lokelma/

The Scottish Medicines Consortium (SMC) has ruled that there’s not enough evidence to support NHS funding of Vifor

After NICE okay, Scots denied access to Vifor’s Veltassa

https://pharmaphorum.com/news/after-nice-okay-scots-denied-access-to-vifors-veltassa/

AstraZeneca and MedImmune will present new data from its Cardiovascular, Renal and Metabolism (CVRM) portfolio for the treatment

AstraZeneca to present the latest cardiovascular research

https://pharmaphorum.com/news/astrazeneca-presents-latest-cardio-research/

AstraZeneca badly needs new drugs on the market as several former blockbusters have been hit by generic competition

AZ’s potassium drug Lokelma finally approved in US

https://pharmaphorum.com/news/azs-lokelma-finally-approved-in-us/

hyperkalaemia